NCT02045823View on ClinicalTrials.gov

OCT Agreement and Precision Study

CompletedOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Normal EyesEyes With GlaucomaEyes With Retinal Disease
Trial Locations (1)

11425

New York VA, Jamaica

All Listed Sponsors
lead

Topcon Medical Systems, Inc.

INDUSTRY

NCT02045823 - OCT Agreement and Precision Study | Biotech Hunter | Biotech Hunter